T Richard Riney Sells 29,702 Shares of Ventas, Inc. (NYSE:VTR) Stock

Ventas, Inc. (NYSE:VTR) EVP T Richard Riney sold 29,702 shares of the firm’s stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $70.45, for a total value of $2,092,505.90. Following the transaction, the executive vice president now directly owns 163,488 shares of the company’s stock, valued at approximately $11,517,729.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of VTR traded down $0.32 during trading hours on Friday, hitting $69.12. The stock had a trading volume of 2,049,358 shares, compared to its average volume of 2,908,066. The company has a debt-to-equity ratio of 1.05, a current ratio of 0.56 and a quick ratio of 0.56. Ventas, Inc. has a 12 month low of $51.80 and a 12 month high of $73.74. The company has a market cap of $24.89 billion, a price-to-earnings ratio of 16.98, a PEG ratio of 4.53 and a beta of 0.28. The firm has a fifty day moving average price of $67.34.

Ventas (NYSE:VTR) last released its earnings results on Friday, April 26th. The real estate investment trust reported $0.99 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.96 by $0.03. The company had revenue of $942.80 million for the quarter, compared to the consensus estimate of $908.61 million. Ventas had a return on equity of 4.04% and a net margin of 12.19%. Ventas’s quarterly revenue was down .1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.22 earnings per share. As a group, analysts forecast that Ventas, Inc. will post 3.83 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, July 12th. Investors of record on Monday, July 1st were given a dividend of $0.7925 per share. The ex-dividend date of this dividend was Friday, June 28th. This represents a $3.17 annualized dividend and a yield of 4.59%. Ventas’s dividend payout ratio (DPR) is presently 77.89%.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Cornerstone Advisors Inc. lifted its position in Ventas by 88.9% during the first quarter. Cornerstone Advisors Inc. now owns 391 shares of the real estate investment trust’s stock valued at $25,000 after purchasing an additional 184 shares in the last quarter. Massey Quick Simon & CO. LLC purchased a new position in shares of Ventas in the first quarter valued at about $26,000. Heritage Wealth Advisors lifted its position in shares of Ventas by 59.3% in the first quarter. Heritage Wealth Advisors now owns 478 shares of the real estate investment trust’s stock valued at $31,000 after acquiring an additional 178 shares in the last quarter. Investors Research Corp purchased a new position in shares of Ventas in the first quarter valued at about $32,000. Finally, Marino Stram & Associates LLC purchased a new position in shares of Ventas in the first quarter valued at about $33,000. Institutional investors own 87.08% of the company’s stock.

A number of research firms recently weighed in on VTR. ValuEngine raised Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Friday, May 17th. Bank of America set a $300.00 price objective on IDEXX Laboratories and gave the company a “buy” rating in a research report on Friday, June 21st. Raymond James set a C$13.50 target price on Secure Energy Services and gave the stock a “strong-buy” rating in a report on Tuesday, April 30th. Morgan Stanley set a $111.00 target price on Procter & Gamble and gave the stock a “buy” rating in a report on Thursday, March 28th. Finally, Mitsubishi UFJ Financial Group lifted their target price on Ventas to $67.00 and gave the stock a “neutral” rating in a report on Wednesday, June 19th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the company. Ventas has a consensus rating of “Hold” and a consensus target price of $64.82.

About Ventas

Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems.

Featured Article: What is the Bid-Ask Spread?

Insider Buying and Selling by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.